Identification of Multiple 5-HT4Partial Agonist Clinical Candidates for the Treatment of Alzheimer’s Disease
- 5 October 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 55 (21) , 9240-9254
Abstract
The cognitive impairments observed in Alzheimer’s disease (AD) are in part a consequence of reduced acetylcholine (ACh) levels resulting from a loss of cholinergic neurons. Preclinically, serotonin 4 receptor (5-HT4) agonists are reported to modulate cholinergic function and therefore may provide a new mechanistic approach for treating cognitive deficits associated with AD. Herein we communicate the design and synthesis of potent, selective, and brain penetrant 5-HT4 agonists. The overall goal of the medicinal chemistry strategy was identification of structurally diverse clinical candidates with varying intrinsic activities. The exposure–response relationships between binding affinity, intrinsic activity, receptor occupancy, drug exposure, and pharmacodynamic activity in relevant preclinical models of AD were utilized as key selection criteria for advancing compounds. On the basis of their excellent balance of pharmacokinetic attributes and safety, two lead 5-HT4 partial agonist candidates 2d and 3 were chosen for clinical development.Keywords
This publication has 27 references indexed in Scilit:
- The 5-Hydroxytryptamine4 Receptor Agonists Prucalopride and PRX-03140 Increase Acetylcholine and Histamine Levels in the Rat Prefrontal Cortex and the Power of Stimulated Hippocampal θ OscillationsThe Journal of Pharmacology and Experimental Therapeutics, 2012
- 2012 Alzheimer's disease facts and figures Alzheimer's Association ∗Alzheimer's & Dementia, 2012
- The worldwide societal costs of dementia: Estimates for 2009Alzheimer's & Dementia, 2010
- 5‐HT4receptor agonists: similar but not the sameNeurogastroenterology & Motility, 2008
- VRX-03011, a novel 5-HT4 agonist, enhances memory and hippocampal acetylcholine effluxNeuropharmacology, 2007
- The cholinergic hypothesis of Alzheimer's disease: a review of progressJournal of Neurology, Neurosurgery & Psychiatry, 1999
- Stereoselective effects of (R)- and (S)-zacopride on cognitive performance in a spatial navigation task in ratsNeuropharmacology, 1996
- Central 5-HT4 receptorsTrends in Pharmacological Sciences, 1995
- 5-HT4 receptor stimulation facilitates acetylcholine release in rat frontal cortexNeuroReport, 1994
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982